MX9708319A - Vacuna de uresa recombinante, multimerica. - Google Patents
Vacuna de uresa recombinante, multimerica.Info
- Publication number
- MX9708319A MX9708319A MX9708319A MX9708319A MX9708319A MX 9708319 A MX9708319 A MX 9708319A MX 9708319 A MX9708319 A MX 9708319A MX 9708319 A MX9708319 A MX 9708319A MX 9708319 A MX9708319 A MX 9708319A
- Authority
- MX
- Mexico
- Prior art keywords
- compositions
- multimeric
- helicobacter
- methods
- recombinant urease
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
- C12N9/80—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in linear amides (3.5.1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55544—Bacterial toxins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
Se proporcionan métodos y composiciones para prevenir y/o tratar infecciones por helicobacter (por ejemplo H, pylori). las composiciones de la invencion, que son usadas en los métodos de la invencion (los cuáles incluyen administracion mucosal de las composiciones) incluyen composiciones que contienen complejos multiméricos de una ureasa helicobacter enzimáticamente inactiva, recombinante en un portador o diluyente farmacéuticamente aceptable; composiciones que contienen (a) un antígeno helicobacter, y (b) un antibiotico, un agente anti-secretante, una sal de bismuto, o una combinacion de éstos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US43104195A | 1995-04-28 | 1995-04-28 | |
US56812295A | 1995-12-06 | 1995-12-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
MX9708319A true MX9708319A (es) | 1998-08-30 |
Family
ID=27028868
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX9708319A MX9708319A (es) | 1995-04-28 | 1997-10-28 | Vacuna de uresa recombinante, multimerica. |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP0831892B1 (es) |
JP (1) | JPH11504633A (es) |
KR (1) | KR19990008155A (es) |
AT (1) | ATE433325T1 (es) |
AU (1) | AU723063B2 (es) |
BR (1) | BR9609871A (es) |
CA (1) | CA2219201A1 (es) |
CZ (1) | CZ342697A3 (es) |
DE (1) | DE69637947D1 (es) |
HU (1) | HUP9801266A3 (es) |
MX (1) | MX9708319A (es) |
NO (1) | NO974969L (es) |
NZ (1) | NZ307017A (es) |
PL (1) | PL185013B1 (es) |
WO (1) | WO1996033732A1 (es) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2637612B1 (fr) * | 1988-10-06 | 1993-09-10 | Pasteur Institut | Sequences de nucleotides codant pour une proteine a activite ureasique |
FR2682122B1 (fr) * | 1991-10-03 | 1995-06-09 | Pasteur Institut | Nouveaux genes d'helicobacter pylori. leur utilisation pour la preparation de souches recombinantes de h. pylori. |
DE19521314A1 (de) * | 1995-06-12 | 1996-12-19 | Max Planck Gesellschaft | Adhärenzgen aus Helicobacter pylori und davon codiertes Polypeptid |
EP0835928A1 (en) * | 1996-10-11 | 1998-04-15 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Berlin | Helicobacter pylori live vaccine |
WO1998021225A1 (en) * | 1996-11-14 | 1998-05-22 | Merieux Oravax | Helicobacter polypeptides and corresponding polynucleotide molecules |
US6248551B1 (en) | 1997-03-28 | 2001-06-19 | Institut Pasteur | Helicobacter aliphatic amidase AmiE polypeptides, and DNA sequences encoding those polypeptides |
GB9718616D0 (en) * | 1997-09-02 | 1997-11-05 | Queen Mary & Westfield College | Oral vaccine |
US6599509B2 (en) | 1997-09-02 | 2003-07-29 | Massachusetts Institute Of Technology | Compositions and methods comprising helicobacter antigens for treatment and prevention of inflammatory bowel disease |
US5985631A (en) | 1997-09-12 | 1999-11-16 | Oravax-Merieux Co. | Method for preventing the activation of inactive, recombinant Helicobacter pylori apourease |
CA2335487A1 (en) | 1998-06-19 | 1999-12-23 | Merieux Oravax | Lt and ct in parenteral immunization methods against helicobacter infection |
US6190667B1 (en) | 1998-06-30 | 2001-02-20 | Institut Pasteur | Methods of inhibiting Helicobacter pylori |
WO2000003730A1 (en) * | 1998-07-16 | 2000-01-27 | Cheil Jedang Corporation | Urease based vaccine against helicobacter infection |
EP1327450B1 (de) * | 2002-01-15 | 2007-08-15 | Bio Life Science Forschungs- und Entwicklungsges.m.b.H. | Orale Vakzinierung mit nackten Tumor-Antigen-Mimotopen |
ATE361097T1 (de) * | 2002-01-15 | 2007-05-15 | Bio Life Science Forschungs & Entwicklungsgesellschaft Mbh | Orale vakzinierung mit dem tumor-antigen-mimotop gln-met-trp-ala-pro-gln-trp-gly-pro-asp |
WO2005113603A1 (en) * | 2004-05-18 | 2005-12-01 | Universite De Lausanne | Eradication of helicobacter infection by activation of stomach mast cells |
CN100460013C (zh) * | 2006-09-05 | 2009-02-11 | 重庆康卫生物科技有限公司 | 口服重组幽门螺杆菌疫苗及其制备方法 |
CN100535119C (zh) * | 2006-11-07 | 2009-09-02 | 上海交通大学医学院附属第九人民医院 | 一种制备唾液链球菌尿素酶基因的方法 |
CN101955545B (zh) * | 2010-09-07 | 2012-07-04 | 四川万可泰生物技术有限责任公司 | 一种多靶点重组基因及其蛋白在防治幽门螺旋杆菌感染中的应用 |
CN113433087A (zh) * | 2021-06-22 | 2021-09-24 | 中南大学 | 一种尿素浓度快速检测方法及检测传感器和应用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5972336A (en) * | 1992-11-03 | 1999-10-26 | Oravax Merieux Co. | Urease-based vaccine against helicobacter infection |
US6290962B1 (en) * | 1992-11-03 | 2001-09-18 | Oravax, Inc. | Urease-based vaccine and treatment for helicobacter infection |
JPH08509873A (ja) * | 1993-05-19 | 1996-10-22 | アンスティテュ・パストゥール | ヘリコバクター感染に対する免疫組成物、該組成物に用いられるポリペプチドおよび該ポリペプチドをコードする核酸配列 |
FR2732605B1 (fr) * | 1995-04-07 | 1997-05-16 | Pasteur Merieux Serums Vacc | Composition destinee a l'induction d'une reponse immunitaire mucosale |
-
1996
- 1996-04-25 DE DE69637947T patent/DE69637947D1/de not_active Expired - Lifetime
- 1996-04-25 AT AT96913166T patent/ATE433325T1/de not_active IP Right Cessation
- 1996-04-25 JP JP8532724A patent/JPH11504633A/ja not_active Ceased
- 1996-04-25 PL PL96323048A patent/PL185013B1/pl not_active IP Right Cessation
- 1996-04-25 NZ NZ307017A patent/NZ307017A/xx unknown
- 1996-04-25 KR KR1019970707680A patent/KR19990008155A/ko not_active Application Discontinuation
- 1996-04-25 AU AU55764/96A patent/AU723063B2/en not_active Ceased
- 1996-04-25 EP EP96913166A patent/EP0831892B1/en not_active Expired - Lifetime
- 1996-04-25 HU HU9801266A patent/HUP9801266A3/hu unknown
- 1996-04-25 CA CA002219201A patent/CA2219201A1/en not_active Abandoned
- 1996-04-25 WO PCT/US1996/005800 patent/WO1996033732A1/en not_active Application Discontinuation
- 1996-04-25 BR BR9609871-6A patent/BR9609871A/pt not_active Application Discontinuation
- 1996-04-25 CZ CZ973426A patent/CZ342697A3/cs unknown
-
1997
- 1997-10-27 NO NO974969A patent/NO974969L/no not_active Application Discontinuation
- 1997-10-28 MX MX9708319A patent/MX9708319A/es not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE69637947D1 (de) | 2009-07-23 |
AU723063B2 (en) | 2000-08-17 |
CZ342697A3 (cs) | 1998-06-17 |
CA2219201A1 (en) | 1996-10-31 |
EP0831892B1 (en) | 2009-06-10 |
JPH11504633A (ja) | 1999-04-27 |
WO1996033732A1 (en) | 1996-10-31 |
ATE433325T1 (de) | 2009-06-15 |
EP0831892A1 (en) | 1998-04-01 |
EP0831892A4 (en) | 2002-06-26 |
HUP9801266A2 (hu) | 1998-08-28 |
NO974969L (no) | 1997-12-23 |
BR9609871A (pt) | 2000-03-28 |
KR19990008155A (ko) | 1999-01-25 |
HUP9801266A3 (en) | 1999-07-28 |
PL185013B1 (pl) | 2003-01-31 |
NZ307017A (en) | 1999-07-29 |
PL323048A1 (en) | 1998-03-02 |
NO974969D0 (no) | 1997-10-27 |
AU5576496A (en) | 1996-11-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX9708319A (es) | Vacuna de uresa recombinante, multimerica. | |
DE69726577D1 (en) | Kristallin form i von clarithromycin | |
IL136249A0 (en) | Suppository containing an acid-labile active compound | |
CA2277824A1 (en) | Dosage composition for nasal delivery and method of use of the same | |
EP0828481A4 (en) | ORAL DELIVERY COMPOSITION FOR INTESTINAL RELEASE AND METHOD OF USE | |
AU2711295A (en) | Combination treatment for inhibiting bone loss | |
GB9922121D0 (en) | Formulation | |
IL140140A0 (en) | Thyroid hormone analogues and methods for their preparation | |
GR3030919T3 (en) | Selective system scan for multizone radiotelephone subscriber units. | |
EP0830456A4 (en) | ISOLATED PROTEIN B NUCLEIC ACID MOLECULE REGULATED BY Fe (FrpB) AND VACCINE USING THE SAME | |
EP0649475A4 (en) | PEPTIDE ALLOWING THE DIAGNOSIS OF INFECTIONS BY -i (T. cruzi) AND THE CORRESPONDING IMMUNIZATION. | |
AU6580494A (en) | Use of clioquinol for treating helicobacter, including (h. pylori), infections and related diseases | |
AU3439799A (en) | Immunization against and treatment for infection by (h.pylori) | |
TR200002767T2 (tr) | Makrolit LHRH Antagonistleri | |
YU10599A (sh) | Amorfni benzotiofeni, postupak dobijanja istih i njihova farmaceutska formulacija | |
TR200002766T2 (tr) | 3',3'-N-Bis-ikameli makrolit LHRH Antagonistleri | |
EP1073436A4 (en) | IMPROVED METHOD FOR ERADICATION OF HELICOBACTER PYLORI | |
AU6701998A (en) | Method for treatment of (h. pylori) | |
GR3032649T3 (en) | CATALASE-BASED ANTI--i(HELICOBACTER PYLORI) IMMUNISING COMPOSITION | |
AU3322100A (en) | Targeted vesicular constructs for cytoprotection and treatment of (h. pylori) infections | |
SE9604322D0 (sv) | Bacterial antigens and vaccine compositions II | |
MX9802809A (es) | Ureasa para el tratamiento de infecciones de helicobacter pylori. | |
UA42741C2 (uk) | Пептид маститної вакцини (варіанти), пептид складного антигенного представлення (варіанти), фармацевтична композиція (варіанти) | |
NZ228023A (en) | 24(r)-scymnol; preparatory processes and pharmaceutical compositions | |
MX9803694A (es) | Derivados de 3-desoxi-3-desclandinosa de eritromicinas a y b. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration | ||
MM | Annulment or lapse due to non-payment of fees |